🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,88 USD

Máx. histórico

61,25

1785 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-51,22%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-2,96%

Cierre anterior

30,79

Rango de hoy

29,85 – 31,44

Volumen hoy

52.805.827

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
42,69 (puede no estar actualizado)
Dividend yield
5,59% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 12 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,76%
Fecha de pago Importe por participación
24/07/2026 0,4300 USD
08/05/2026 0,4300 USD
23/01/2026 0,4300 USD
07/11/2025 0,4300 USD
25/07/2025 0,4300 USD
09/05/2025 0,4300 USD
24/01/2025 0,4300 USD
08/11/2024 0,4200 USD
26/07/2024 0,4200 USD
09/05/2024 0,4200 USD
25/01/2024 0,4200 USD
09/11/2023 0,4100 USD
27/07/2023 0,4100 USD
11/05/2023 0,4100 USD
26/01/2023 0,4100 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/04/1996 10,56 10,89 10,56 10,75 +1,49% 3,18% 4.036.609
26/04/1996 10,59 10,73 10,52 10,59 +0,38% 2,05% 7.438.921
25/04/1996 10,67 10,71 10,50 10,56 -0,74% 2,04% 9.921.724
24/04/1996 10,87 10,87 10,46 10,63 -1,83% 3,82% 13.162.774
23/04/1996 11,03 11,03 10,79 10,83 -1,79% 2,15% 6.148.193
22/04/1996 11,07 11,17 10,79 11,03 -0,36% 3,39% 7.757.651
19/04/1996 10,89 11,11 10,87 11,07 +1,82% 2,18% 7.601.448
18/04/1996 10,85 11,03 10,85 10,87 +0,18% 1,64% 7.245.407
17/04/1996 10,87 10,87 10,75 10,85 -0,54% 1,09% 6.728.736
16/04/1996 10,99 11,03 10,85 10,91 -0,54% 1,62% 7.790.536
15/04/1996 10,91 11,13 10,87 10,97 +0,54% 2,35% 9.900.854
12/04/1996 10,67 10,93 10,65 10,91 +2,60% 2,59% 6.515.617
11/04/1996 10,57 10,63 10,28 10,63 +0,94% 3,36% 13.504.270
10/04/1996 10,87 10,89 10,36 10,54 -3,27% 4,91% 9.300.074
09/04/1996 11,07 11,11 10,83 10,89 -1,43% 2,50% 6.329.692
08/04/1996 11,01 11,05 10,93 11,05 -1,93% 1,08% 9.032.569
04/04/1996 11,39 11,39 11,25 11,27 -1,04% 1,22% 5.845.906
03/04/1996 11,35 11,44 11,21 11,39 +0,17% 2,09% 8.799.846
02/04/1996 11,13 11,37 11,09 11,37 +2,68% 2,49% 10.943.050
01/04/1996 10,79 11,09 10,77 11,07 +4,09% 2,93% 8.828.936
29/03/1996 10,75 10,83 10,59 10,63 -0,55% 2,21% 5.478.481
28/03/1996 10,79 10,79 10,59 10,69 +0,00% 1,83% 4.746.794
27/03/1996 10,75 10,79 10,63 10,69 -1,64% 1,47% 8.738.503
26/03/1996 10,85 11,01 10,79 10,87 +1,48% 2,00% 8.483.014
25/03/1996 10,71 10,89 10,65 10,71 +0,00% 2,21% 6.707.867
22/03/1996 10,83 10,83 10,61 10,71 +1,31% 2,01% 10.994.906
21/03/1996 10,28 10,69 10,26 10,57 +5,52% 4,23% 20.876.156
20/03/1996 10,08 10,10 9,92 10,02 +0,40% 1,76% 11.077.118
19/03/1996 10,12 10,22 9,94 9,98 +0,60% 2,73% 12.434.249
18/03/1996 10,02 10,12 9,80 9,92 -0,20% 3,16% 9.472.720